FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

PAI Holdings, LLC. dba Pharmaceutical Associates Citalopram Oral Solution Recall

Citalopram Oral Solution, USP 20 mg/10 mL, 10 mL unit dose cups, Rx Only, Mfg for: Phar…

PAI Holdings, LLC. dba Pharmaceutical Associates Inc · Greenville, SC

Risk level
Class III
Reported by FDA
Oct 14, 2020
Recall ID
D-0015-2021
Check your lot numberHow we source this data

Summary

PAI Holdings, LLC. dba Pharmaceutical Associates recalled Citalopram Oral Solution starting Sep 9, 2020. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0015-2021 on Oct 14, 2020. Reason: Failed Impurities/Degradation Specifications; high out of specification results obtained at the 9 month stability timepoint. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications; high out of specification results obtained at the 9 month stability timepoint

Product description

Citalopram Oral Solution, USP 20 mg/10 mL, 10 mL unit dose cups, Rx Only, Mfg for: Pharmaceutical Associates, Inc. Greenville, SC 29605 NDC 0121-1696-40

Lot numbers, UPCs & expiration codes

Lots: C1EE Exp. 04/2021, BD82 Exp. 11/2020, BD83 Exp. 11/2020, C16D Exp. 02/2021, C563 Exp. 11/2021, C574 Exp. 11/2021

Where it was sold

Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0015-2021
Classification
Class III
Status
Terminated
Recall initiated
Sep 9, 2020
FDA report date
Oct 14, 2020
Quantity
13480 cups
Recall type
Voluntary: Firm initiated
Recalling firm
PAI Holdings, LLC. dba Pharmaceutical Associates Inc

Original FDA data

Every field from FDA enforcement report D-0015-2021, exactly as published.

Show all FDA fields
City
Greenville
State
SC
Status
Terminated
Country
United States
Event ID
86409
Address
1700 Perimeter Rd
Code information
Lots: C1EE Exp. 04/2021, BD82 Exp. 11/2020, BD83 Exp. 11/2020, C16D Exp. 02/2021, C563 Exp. 11/2021, C574 Exp. 11/2021
Postal code
29605-5252
Report date
Oct 14, 2020
Product type
Drugs
Recall number
D-0015-2021
Classification
Class III
Recalling firm
PAI Holdings, LLC. dba Pharmaceutical Associates Inc
Product quantity
13480 cups
Termination date
Feb 22, 2022
Reason for recall
Failed Impurities/Degradation Specifications; high out of specification results obtained at the 9 month stability timepoint
Voluntary / mandated
Voluntary: Firm initiated
Product description
Citalopram Oral Solution, USP 20 mg/10 mL, 10 mL unit dose cups, Rx Only, Mfg for: Pharmaceutical Associates, Inc. Greenville, SC 29605 NDC 0121-1696-40
Distribution pattern
Nationwide.
Recall initiation date
Sep 9, 2020
Initial firm notification
Letter
Center classification date
Oct 5, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0015-2021, published Oct 14, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls